期刊文献+

1例慢性阻塞性肺疾病患者药物治疗的药学监护 被引量:3

Pharmaceutical Care during Medical Treatment on An Inpatient with Chronic Obstructive Pulmonary Disease
下载PDF
导出
摘要 目的:通过临床药师对l例慢性阻塞性肺疾病患者药学监护的过程,探讨药师在临床治疗中发挥的作用。方法:针对具体病例,协助医师为患者制定有效的治疗方案,为患者建立药历,关注患者用药期间出现的不良反应,提出合理的药学监护措施及健康教育计划。结果:临床药师为患者实施药学监护可以提高药物治疗效果,减少用药风险。结论:临床药师参与临床药物治疗,可使用药更规范合理。 Objective: To discuss the role of pharmacists in clinical treatment in the process of pharmaceutical care by clinical pharmacists on an inpatient with chronic obstructive pulmonary disease (COPD). Methods: Clinical pharmacists according to the patient condition assisted physicians to develop an effective plan of treatment for the patient, established medication record, paid close attention to adverse drug reactions of the patient during medication, and put forward reasonable measures of pharmaceutical care and health education programs. Results: Pharmaceutical care given by clinical pharmacists can improve the effectiveness of medical treatment and reduce the risks caused by drug use. Conclusion: The pharmacist participation in clinical drug therapy could make drug use more normative and reasonable.
作者 郭作兵
出处 《中国执业药师》 CAS 2012年第3期37-40,共4页 China Licensed Pharmacist
关键词 慢性阻塞性肺疾病 药学监护 临床药师 Chronic Obstructive Pulmonary Disease Pharmaceutical Care Clinical Pharmacist
  • 相关文献

参考文献9

二级参考文献111

共引文献185

同被引文献35

  • 1伍雪英,龚玉来,周斌.加巴喷丁单药治疗癫痫50例临床观察[J].四川医学,2007,28(4):387-388. 被引量:2
  • 2李迪华,徐家立.卡马西平过敏反应31例临床分析[J].中国药物与临床,2007,7(6):481-482. 被引量:4
  • 3毛素芳,晏廷念.硝普钠临床应用的药学监护[J].中国药房,2007,18(29):2319-2320. 被引量:13
  • 4Zaccara G, Franciotta D ,Perucca E. Idiosyncratic adverse reac- tions to antiepilep ticdrugs[J]. Epilepsia, 2007,48 (7) : 1223-1244.
  • 5Patsalos PN,Sander JW. Towards an improved risk-benefit ratio[J]. Drug Saf, 1994,11 ( 1 ) : 37-37.
  • 6National Nosocomial Infections Surveillance System. Na-tional Nosocomial Infections Surveillance (NNIS) Sys-tem Report, data summary from January 1992 throughJune 2004,issued October 2004[J]tJ4m J Infect Controly2004,32(8):470.
  • 7杨贺,芮芳,钟丽英.尿液中分离出耐万古霉素的屎肠球菌 1 例[J].传统医药,2011,20(8):76.
  • 8Garazzino S,De Rosa FG,Bargiacchi O, et al.Haemato-logical safety of long-term therapy with linezolid[J]. Int JAntimicrob Agents ,2007,29(4): 480.
  • 9McCollum M,Sorensen SV,Liu LZ,et al.A comparisonof costs and hospital length of stay assoctiated with intra-venous/oral linezolid or intravenous vancomycin treat-ment of complicated skin and sofl-tissue infections causedby suspected or confirmed methicillin-resistant staphylo-coccus aureus in elderly US patients[J].C//? Ther, 2007,29(3):469.
  • 10Harred J F, Knight A R, Mclntyre J S. Inventors. Dow chemical carapany, assignee eXpoXidation process[ J]. US Patent 3. 2012, 3( 1 7). 1927-1904.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部